PERIOD ENDING 30-Sep-07 30-Jun-07 31-Mar-07 30-Sep-06 (ALL #'s in 000)
Total Revenue - - 62 1
Cost of Revenue - - 54 -
Gross Profit - - 8 1
Operating Expenses
Research Development 2 4 3 -
Selling General and Administrative 249 563 260 6
Non Recurring - - - -
Others 50 60 20 5
Total Operating Expenses - - - -
Operating Income or Loss (301) (627) (275) (10)
Income from Continuing Operations
Total Other Income/Expenses Net (121) 4 - -
Earnings Before Interest And Taxes (422) (623) (275) (10)
Interest Expense 7 7 11 1
Income Before Tax (429) (630) (286) (12)
Income Tax Expense - - - -
Minority Interest - - - -
Net Income From Continuing Ops (429) (630) (286) (12)
Non-recurring Events Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income (429) (630) (286) (12)
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares ($429) ($630) ($286) ($12)
0 members recommend this.
Chairman & CEO Wayne Rodrigue sheds light on Exousia's growth opportunities in Q3-Q4
